Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Non-inferiority Trial to Assess the Safety and Performance of the Evolution Coronary Stent (Evolve)

This study has been completed.
Information provided by (Responsible Party):
Boston Scientific Corporation Identifier:
First received: May 31, 2010
Last updated: May 1, 2016
Last verified: May 2016